NCT05933239View on ClinicalTrials.gov

Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

68GaNOTA-Anti-MMR-VHH2

Injection of the radiopharmaceutical and PET/CT imaging

Trial Locations (1)

1090

RECRUITING

Universitair Ziekenhuis Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER